Tags: Drug.

Ibodutant is a candidate drug against irritable bowel syndrome developed by The Menarini Group. As of May 2008 it is undergoing a multicentre double blind dose finding study.

Ibodutant_structure.svg
ATC prefix
none
FDA UNII code
1H7RSQ28BJ
IUPAC name
Nα-[(1-[(6-methyl-1-benzothien-2-yl)carbonyl]aminocyclopentyl)carbonyl]-N-[1-(tetrahydro-2H-pyran-4-ylmethyl)piperidin-4-yl]methyl-(D)-phenylalaninamide
PubChem
11527495

Loading...

This page contains content from the copyrighted Wikipedia article "Ibodutant"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.